Improving adoptive immune therapy using genetically engineered T cells

被引：0
|
作者：
Stroncek, David F. [1 ]
机构：
[1] NIH, Cell Proc Sect, Dept Transfus Med, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2016年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
K12
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Adoptive immunotherapy of cancer utilizing genetically engineered lymphocytes
    Ikeda, Hiroaki
    Shiku, Hiroshi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (07) : 903 - 909
  • [42] Genetically engineered Sertoli cells as a vehicle for gene therapy
    Halley, Katie R.
    Dufour, Jannette M.
    XENOTRANSPLANTATION, 2007, 14 (05) : 548 - 549
  • [43] Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
    Morgan, Richard A.
    Johnson, Laura A.
    Davis, Jeremy L.
    Zheng, Zhili
    Woolard, Kevin D.
    Reap, Elizabeth A.
    Feldman, Steven A.
    Chinnasamy, Nachimuthu
    Kuan, Chien-Tsun
    Song, Hua
    Zhang, Wei
    Fine, Howard A.
    Rosenberg, Steven A.
    HUMAN GENE THERAPY, 2012, 23 (10) : 1043 - 1053
  • [44] ADOPTIVE TRANSFER OF GENETICALLY ENGINEERED SIV-SPECIFIC T CELLS LIMITS THE NUMBER OF SIV FOUNDER VIRUSES IN RHESUS MACAQUES
    Ayala, Victor
    Trivett, Matthew
    Keele, Brandon
    Barsov, Eugene
    Coren, Lori
    Jain, Sumiti
    Piatak, Michael
    Estes, Jake
    Gorelick, Robert
    Chertova, Elena
    Smedley, Jeremy
    Lifson, Jeffrey
    Ott, David
    Ohlen, Claes
    JOURNAL OF MEDICAL PRIMATOLOGY, 2014, 43 (05) : 382 - 383
  • [45] Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells
    Davies, David M.
    Foster, Julie
    van der Stegen, Sjoukje J. C.
    Parente-Pereira, Ana C.
    Chiapero-Stanke, Laura
    Delinassios, George J.
    Burbridge, Sophie E.
    Kao, Vincent
    Liu, Zhe
    Bosshard-Carter, Leticia
    van Schalkwyk, May C. I.
    Box, Carol
    Eccles, Suzanne A.
    Mather, Stephen J.
    Wilkie, Scott
    Maher, John
    MOLECULAR MEDICINE, 2012, 18 (04) : 565 - 576
  • [46] Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules
    Kim, Min Soo
    Ma, Jennifer S. Y.
    Yun, Hwayoung
    Cao, Yu
    Kim, Ji Young
    Chi, Victor
    Wang, Danling
    Woods, Ashley
    Sherwood, Lance
    Caballero, Dawna
    Gonzalez, Jose
    Schultz, Peter G.
    Young, Travis S.
    Kim, Chan Hyuk
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (08) : 2832 - 2835
  • [47] Immune therapy with genetically modified tumor cells
    Topf, N
    Schmiegel, WH
    INTERNIST, 1996, 37 (04): : 374 - 381
  • [48] Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells
    David M. Davies
    Julie Foster
    Sjoukje J. C. van der Stegen
    Ana C. Parente-Pereira
    Laura Chiapero-Stanke
    George J. Delinassios
    Sophie E. Burbridge
    Vincent Kao
    Zhe Liu
    Leticia Bosshard-Carter
    May C. I. van Schalkwyk
    Carol Box
    Suzanne A. Eccles
    Stephen J. Mather
    Scott Wilkie
    John Maher
    Molecular Medicine, 2012, 18 : 565 - 576
  • [49] Suicide Gene Therapy of Glioma Using Genetically Engineered Human Mesenchymal Stem Cells
    Namba, Hiroki
    Li, Shaoyi
    Tokuyama, Tsutomu
    Yamamoto, Junkoh
    Yokota, Naoki
    MOLECULAR THERAPY, 2006, 13 : S139 - S139
  • [50] Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells
    Berry, L. J.
    Moeller, M.
    Darcy, P. K.
    TISSUE ANTIGENS, 2009, 74 (04): : 277 - 289
12345